0001209191-22-022110.txt : 20220401
0001209191-22-022110.hdr.sgml : 20220401
20220401201647
ACCESSION NUMBER: 0001209191-22-022110
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220330
FILED AS OF DATE: 20220401
DATE AS OF CHANGE: 20220401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Keyt Bruce
CENTRAL INDEX KEY: 0001787362
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39045
FILM NUMBER: 22800182
MAIL ADDRESS:
STREET 1: 325 E. MIDDLEFIELD ROAD
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IGM Biosciences, Inc.
CENTRAL INDEX KEY: 0001496323
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770349194
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 325 E MIDDLEFIELD ROAD
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-965-7873
MAIL ADDRESS:
STREET 1: 325 E MIDDLEFIELD ROAD
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
FORMER COMPANY:
FORMER CONFORMED NAME: Palingen, Inc.
DATE OF NAME CHANGE: 20100712
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-30
0
0001496323
IGM Biosciences, Inc.
IGMS
0001787362
Keyt Bruce
C/O IGM BIOSCIENCES, INC.
325 E. MIDDLEFIELD ROAD
MOUNTAIN VIEW
CA
94043
0
1
0
0
Chief Scientific Officer
Common Stock
2022-03-30
4
M
0
7500
0.93
A
47515
D
Common Stock
2022-03-30
4
S
0
7500
28.4967
D
40015
D
Common Stock
1013
I
See footnote
Stock Option (right to buy)
0.93
2022-03-30
4
M
0
7500
0.00
D
2023-01-12
Common Stock
7500
136256
D
The option exercise and sale were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $28.18 to $29.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
The shares are held directly by the reporting person's spouse.
The shares subject to the option are vested and exercisable as of the date hereof.
/s/ Misbah Tahir, by power of attorney
2022-04-01